Chris Vazquez - May 23, 2024 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Chief Accounting Officer
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Chris Vazquez
Stock symbol
BDSX
Transactions as of
May 23, 2024
Transactions value $
$0
Form type
4
Date filed
5/23/2024, 07:15 PM
Previous filing
May 10, 2024
Next filing
Aug 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise +880 +8.88% 10.8K May 23, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Series A Non-Voting Convertible Preferred Stock Options Exercise $0 -22 -100% $0.00* 0 May 23, 2024 Common Stock 880 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.